Rehovot, Israel

Tova Waks

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 4.2

ph-index = 5

Forward Citations = 753(Granted Patents)


Location History:

  • Petah Tikva, IL (1999)
  • 49372 Petach Tikva, IL (2010)
  • Petach Tikva, IL (2012 - 2024)
  • Rehovot, IL (2016 - 2024)

Company Filing History:


Years Active: 1999-2024

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Innovator in Cancer Research: Tova Waks

Introduction: Tova Waks, a prominent inventor located in Rehovot, Israel, has made significant contributions to cancer research through her groundbreaking inventions. With a total of 9 patents to her name, Waks is at the forefront of developing innovative therapies utilizing chimeric antigen receptor (CAR) T-cells.

Latest Patents: Waks's latest patents showcase her expertise in the field of immunotherapy. One notable patent describes T-cells modified to express at least two different chimeric antigen receptors, one of which targets CD138, HER2, or CD24, while the other targets a different antigen from the same group. This innovation not only enhances the efficacy of cancer treatment, particularly for ovarian cancer, but also includes the preparation of pharmaceutical compositions incorporating these CAR T-cells.

Another significant patent by Waks details T-cells expressing dual chimeric antigen receptors that specifically bind to CD138 and CD38. This patent emphasizes the use of these engineered T-cells in treating multiple myeloma and provides methods for preparing such advanced cell therapies.

Career Highlights: Tova Waks has collaborated with leading research entities, including Yeda Research and Development Company and the Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center. Her work has been pivotal in advancing the understanding and treatment of various cancers through innovative cellular therapies.

Collaborations: Throughout her career, Waks has worked closely with notable scientists such as Zelig Eshhar and Gideon Gross. Their combined expertise has contributed substantially to the field of cancer research, leading to significant advancements in CAR T-cell therapy.

Conclusion: Tova Waks stands out as an influential inventor, pushing the boundaries of cancer treatment through her innovative patent developments. Her work continues to inspire new therapies that hold the potential to change the landscape of cancer care, providing hope to patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…